Publicacións nas que colabora con Sara Agraso Busto (4)

2019

  1. EP1.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

    Journal of Thoracic Oncology, Vol. 14, Núm. 10, pp. S1037

  2. Efficacy and safety of Crizotinib in patients with ALK positive non small cell lung cancer (NSCLC): Real-world findings.

    Journal of Clinical Oncology, Vol. 37, Núm. 15_suppl, pp. e20636-e20636

  3. Galician lung cancer group: Afatinib's data as first-line treatment for elderly patients

    JOURNAL OF CLINICAL ONCOLOGY, Vol. 37, Núm. 15 Sup, pp. e20662

  4. Third and successive–lines of chemotherapy in NSCLC patients without therapeutic targets: Experience of the Grupo Gallego de Cáncer de Pulmón.

    Journal of Clinical Oncology, Vol. 37, Núm. 15_suppl, pp. e20579-e20579